[1]
M. Khawaja, M. Zakaria, T. Gul, B. Hameed, and N. M. Khan, “Beneficial effects of SGLT2 Inhibitors on Fatty Liver in Type 2 Diabetes Mellitus”, IJBR, vol. 3, no. 7, pp. 745–749, Jul. 2025, doi: 10.70749/ijbr.v3i7.2075.